Information:
Fel:
ID
14848
Beskrivning
A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01839604
Länk
https://clinicaltrials.gov/show/NCT01839604
Nyckelord
Versioner (1)
- 2016-05-01 2016-05-01 -
Uppladdad den
1 maj 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Advanced Adult Hepatocellular Carcinoma NCT01839604
Eligibility Advanced Adult Hepatocellular Carcinoma NCT01839604
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Adult Hepatocellular Carcinoma NCT01839604
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age and japanese, taiwanese
Item
aged at least 18 years. patient from japan and taiwan aged at least 20 years
boolean
C0001779 (UMLS CUI [1])
C1556094 (UMLS CUI [2])
C1556096 (UMLS CUI [3])
C1556094 (UMLS CUI [2])
C1556096 (UMLS CUI [3])
hcc
Item
histologically or cytologically confirmed hcc (with the exception of fibrolamellar carcinoma or mixed variants of hcc with fibrolamellar histology or clinically diagnosed hcc for patients with difficulty in obtaining histological diagnosis)
boolean
C2239176 (UMLS CUI [1])
sorafenib
Item
relapsed, refractory, intolerant or unlikely to benefit from sorafenib (for example due to comorbidity)
boolean
C1516119 (UMLS CUI [1])
hcc not suitable to receive local therapy
Item
hcc not suitable to receive local therapy
boolean
C2239176 (UMLS CUI [1,1])
C1517925 (UMLS CUI [1,2])
C1517925 (UMLS CUI [1,2])
disease recurred or was refractory to last therapy (local or systemic)
Item
disease recurred or was refractory to last therapy (local or systemic)
boolean
C0854794 (UMLS CUI [1])
ecog
Item
eastern cooperative oncology group (ecog) performance status 0-1 with no deterioration over the previous 2 weeks and minimum life expectancy of 8 weeks
boolean
C1520224 (UMLS CUI [1])
systemic treatment
Item
more than 2 prior systemic treatments for hcc
boolean
C0920425 (UMLS CUI [1])
prior grade 3 hematologic toxicity related to treatment with a jak or stat3 inhibitor
Item
prior grade 3 hematologic toxicity related to treatment with a jak or stat3 inhibitor
boolean
C3827109 (UMLS CUI [1])
C2983787 (UMLS CUI [2])
C0279037 (UMLS CUI [3])
C2983787 (UMLS CUI [2])
C0279037 (UMLS CUI [3])
hepatic encephalopathy
Item
presence of hepatic encephalopathy within 4 weeks of 1st dose
boolean
C0019151 (UMLS CUI [1])
ascites
Item
uncontrolled massive ascites
boolean
C0003962 (UMLS CUI [1])
bleeding
Item
high likelihood of bleeding
boolean
C4039184 (UMLS CUI [1])